Press Releases
Cobra Bio Secures $3.3 Million to Develop DNA Vaccine...
U.K.-based Cobra Biologics and noted medical university the Karolinska Institute, which is based in Sweden, secured millions in emergency funding from Horizon 2020 to support...
Press Releases
GigaGen Works to Develop Passive, Convalescent COVID-19 Therapy
GigaGen is developing a recombinant polyclonal antibody therapy (rCIG) to treat COVID-19. First uses are envisioned as treatments for severely ill coronavirus patients and individuals...
Press Releases
ideaPoint and WideTrial Launch Global Expanded Access Platform for...
Anaqua’s ideaPoint, a provider of medical affairs and innovation management solutions, announced a strategic partnership with clinical data company WideTrial to facilitate greater access to...
Press Releases
Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus...
Abbott announced that the U.S. FDA has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus...
Press Releases
Bora strengthens business development team to support US growth
Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO) which specializes in immediate and modified release oral solids and packaging, has announced the appointment...
Drug Research
Destroying DNA to Save the Genome – Study Offers...
Sepsis is a life-threatening condition that kills millions annually; it is poorly understood and has no specific treatment. Now, researchers from Tata Memorial Centre, India,...
Drug Research
C2 PHARMA Opens Government and Research Access to Safety...
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.